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Supplementary methods 
 
Definition of existing diabetes, gestational diabetes and glycosuria 
At recruitment, women were asked by questionnaire about existing diabetes and any previous history 
of gestational diabetes. Information on glycosuria (recorded as none, trace, +, ++, +++ or more) was 
abstracted from the records of each antenatal clinic visit made by the woman (median number, 14 per 
woman). The practice in the UK at the time was for all women to be offered urine tests for glycosuria 
at each antenatal clinic visit. Universal screening of women with a random or fasting blood glucose 
level or with an oral glucose tolerance test was not undertaken, and diagnostic tests for gestational 
diabetes will only have been undertaken in women with established risk factors (family history, 
previous history of gestational diabetes or macrosomic birth, South Asian ethnicity) or persistent 
glycosuria. Glycosuria was defined as a record of at least ++ (equal to 13.9 mmol/l or 250 mg/100 ml 
according to the manufacturer (Bayer)) on at least two occasions at any time during the pregnancy 
(1). Women were classified into one of four mutually exclusive categories: no evidence of glycosuria 
or diabetes; existing diabetes before the pregnancy; gestational diabetes (i.e. a diagnosis in the 
medical records of gestational diabetes in any woman with no history of existing diabetes); and 
persistent glycosuria (i.e. ++ glycosuria on two occasions in women with no evidence of existing or 
gestational diabetes). 
 
Parental comparison approach 
Proof of concept has been illustrated in ALSPAC with maternal smoking in pregnancy which is 
strongly associated with lower offspring birth weight, whereas paternal smoking is only weakly 
associated (and not associated at all after mutual adjustment). In contrast, paternal and maternal 
smoking in pregnancy are similarly associated with offspring BMI, even after mutual adjustment, 
suggesting that these associations are non-causal and generated by confounding (2). We have also 
used this approach to investigate the likely causal role of prenatal paracetamol exposure in the 
development of asthma in ALSPAC(3). 
 
Inverse probability weighting 
Inverse probability weighting has been proposed as a way to correct for selection bias (4).  By 
assigning to each subject a weight that is the inverse of the probability of his/her selection based on a 
given set of covariates and exposure, inverse probability weighting creates a pseudo-population in 
which effect measures are not affected by selection bias (provided that the outcome in the 
uncensored subjects truly represents the outcome in the censored subjects for the same values of 
covariates and exposure). We used this approach by estimating for each woman, the probability of 
her selection for given values of covariates (ie. the characteristics for which differences between 
excluded and included women were found to be statistically significant, including the exposure – see 
online Table E1) and assigning her a weight that is the inverse of that probability.  
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Figure E1. Directed acyclic graph showing potential confounders and mediators of the associations 
between maternal intake of free sugar in pregnancy and offspring respiratory and atopic outcomes      
  
Figure E2. Participant flow 
14,541 recruited ALSPAC mothers
13,972 singleton or twin children alive at 1 year
12,078 with information on maternal diet in 
pregnancy 
8,956 with information on at least one 
outcome variable at 7-9 years of age
7,677 with 
information 
on asthma
7,762 with 
information 
on wheeze
6,117 with 
information 
on atopy
4,843 with 
information 
on total IgE
5,308 with 
information 
on FEV1
5,387 with 
information 
on FVC
4,434 with 
information on 
atopic/non-
atopic asthma
 
  
Table E1. Characteristics of mothers and offspring who were included in analyses and those who 
were excluded (n=12,078) 
 
 Included  (n=8,956) Excluded (n=3,122) P 
Maternal free sugar intake in pregnancy 
(g/day) 
59.1 (32.5) 64.5 (39.5) < .001 
Mother’s age (years), m (sd) 28.9 (4.6) 26.5 (5.1) < .001 
Parity, % 
0 
1 
≥2 
 
45.4 
36.0 
18.6 
 
43.0 
34.3 
22.8 
 
 
< .001 
Sex of child, % 
Male  
Female 
 
51.2 
48.8 
 
52.1 
47.9 
 
0.38 
Multiple pregnancy, % 
Singleton 
Twin  
 
97.5 
2.5 
 
97.2 
2.8 
 
0.27 
Season of birth, % 
Winter 
Spring 
Summer 
Autumn 
 
16.2 
27.0 
30.1 
26.7 
 
16.0 
26.5 
31.4 
26.2 
 
 
0.60 
Breastfeeding duration, % 
Never 
<3 months 
3-6 months 
≥6 months 
 
21.2 
31.5 
13.8 
33.5 
 
35.6 
32.9 
10.4 
21.0 
 
 
< .001 
Mother’s educational level, % 
Certificate of Secondary Education 
Vocational 
Ordinary level 
Advanced level 
Degree  
 
15.5 
9.0 
35.5 
25.0 
15.0 
 
32.8 
12.3 
32.5 
15.6 
6.9 
 
 
< .001 
Maternal ethnicity, % 
White  
Non-white  
 
98.1 
1.9 
 
95.5 
4.5 
 
< .001 
Housing tenure, % 
Owned/mortgaged 
Council rented 
Non-council rented 
 
83.7 
9.5 
6.9 
 
62.3 
24.0 
13.7 
 
 
< .001 
Financial difficulties, % 
No 
Yes 
 
82.9 
17.1 
 
77.1 
22.9 
 
< .001 
Maternal history of atopic diseases, % 
No 
Yes 
 
31.7 
68.3 
 
31.1 
68.9 
 
0.54 
Maternal anxiety score in pregnancy, %    
0-9 
10-14 
15-20 
≥20 
21.3 
25.8 
25.8 
27.2 
16.9 
21.4 
24.7 
37.1 
 
< .001 
Maximum maternal tobacco exposure, % 
None  
Passive only 
1-9 cig/day 
10-19 cig/day 
20+ cig/day  
 
26.5 
46.0 
7.9 
11.4 
8.3 
 
17.5 
35.8 
9.6 
20.0 
17.1 
 
 
< .001 
Maternal paracetamol use during pregnancy, 
% 
No 
Yes  
 
37.7 
62.4 
 
35.2 
64.8 
 
0.02 
Maternal antibiotic use during pregnancy, % 
No 
Yes 
 
84.0 
16.0 
 
85.4 
14.6 
 
0.06 
Maternal supplement use during pregnancy, % 
No 
Yes 
 
43.1 
56.9 
 
41.1 
58.9 
 
0.05 
Maternal infections in pregnancy, % 
No 
Yes 
 
54.2 
45.8 
 
53.2 
46.8 
 
0.33 
Total energy intake (kJ/day), m (sd) 7259 (1967) 7163 (2152) 0.02 
Maternal pre-pregnancy BMI, % 
<18.50 kg/m² 
18.50-24.99 kg/m² 
25.00-29.99 kg/m² 
≥30.00 kg/m² 
 
 
4.3 
75.4 
15.0 
5.3 
 
 
6.4 
72.8 
15.1 
5.8 
 
 
 
< .001 
Birth weight, % 
<2500 g 
2500-2999 g 
3000-3499 g  
3500-3999 g 
≥4000 g 
 
4.3 
13.8 
35.4 
33.2 
13.3 
 
5.7 
15.1 
36.6 
30.8 
11.8 
 
 
< .001 
Gestational age (weeks), m (sd) 39.5 (1.8) 39.4 (1.9) 0.04 
Child’s BMI at 7, % 
<15.00 kg/m² 
15.00-17.49 kg/m² 
17.50-20.49 kg/m² 
≥20.50 kg/m² 
 
 
28.1 
52.5 
15.2 
4.2 
 
 
31.6 
43.9 
17.5 
7.0 
 
 
 
0.52 
Maternal weight gain during pregnancy, % 
Quartile 1 
Quartile 2 
Quartile 3 
Quartile 4 
 
25.3 
24.8 
25.5 
24.4 
 
28.4 
24.4 
22.1 
25.2 
 
 
< .001 
Table E2. Associations between maternal free sugar intake during pregnancy and total IgE, FEV1, FVC and FEF25-75 in the offspring 
GMR: geometric mean ratio 
a Controlling for energy intake  
b Controlling for energy intake, smoking, infections, supplements, antibiotics and paracetamol use during pregnancy; maternal educational level, 
housing tenure, financial difficulties, ethnicity, age, parity, history of atopic diseases, anxiety; sex of child, season of birth, multiple pregnancy, 
breastfeeding duration 
  
 Maternal free sugar intake during pregnancy  
 1st quintile 2nd quintile 3rd quintile    4th quintile     5th quintile Per quintile P-trend 
IgE (n=4,843)        
GMRa (95% CI) 1.00 1.12 (0.97-1.30) 0.95 (0.82-1.11) 1.04 (0.88-1.22) 1.07 (0.88-1.30) 1.00 (0.96-1.05) 0.95 
GMRb (95% CI) 1.00 1.15 (0.99-1.33) 0.99 (0.85-1.15) 1.10 (0.93-1.30) 1.18 (0.97-1.43) 1.02 (0.98-1.07) 0.30 
FEV1 (n=5,308)        
βa (95% CI) 0.00 -0.04 (-0.11, 0.03) 0.02 (-0.05, 0.09) 0.00 (-0.07, 0.08) -0.03 (-0.12, 0.06) 0.00 (-0.02, 0.02) 1.00 
βb (95% CI) 0.00 -0.04 (-0.11, 0.03) 0.01 (-0.06, 0.09) -0.00 (-0.08, 0.08) -0.02 (-0.11, 0.07) 0.00 (-0.02, 0.02) 0.92 
FVC (n=5,387)        
βa (95% CI) 0.00 -0.03 (-0.10, 0.03) 0.02 (-0.05, 0.09) 0.01 (-0.07, 0.09) -0.07 (-0.16, 0.02) -0.01 (-0.03, 0.01) 0.54 
βb (95% CI) 0.00 -0.03 (-0.10, 0.03) 0.02 (-0.06, 0.09) 0.00 (-0.07, 0.08) -0.07 (-0.16, 0.02) -0.01 (-0.03, 0.01) 0.50 
FEF25-75 (n=5,321)        
βa (95% CI) 0.00 -0.02 (-0.09, 0.05) -0.03 (-0.10, 0.04) -0.01 (-0.08, 0.07) -0.04 (-0.13, 0.05) -0.01 (-0.03, 0.01) 0.56 
βb (95% CI) 0.00 -0.02 (-0.09, 0.05) -0.03 (-0.10, 0.05) -0.00 (-0.08, 0.08) -0.01 (-0.10, 0.09) 0.00 (-0.02, 0.02) 0.99 
Table E3. Associations between maternal free sugar intake during pregnancy and childhood atopy and atopic asthma further adjusted for 
potential mediators and child’s free sugar intake at age 3 years 
a Controlling for maternal pre-pregnancy BMI, gestational age at delivery, birth weight, maternal weight gain during pregnancy, and child’s BMI 
at 7, in addition to all the potential confounders previously mentioned  
b Controlling for child’s free sugar intake at age 3 years, in addition to all the potential confounders previously mentioned 
  
 Free sugar intake  
 1st quintile 2nd quintile 3rd quintile    4th quintile     5th quintile Per quintile P-trend 
Atopy (n=6,117)        
ORa (95% CI) 
ORb (95% CI) 
1.00 
1.00 
0.97 (0.79-1.19) 
0.95 (0.76-1.17) 
1.08 (0.88-1.33) 
1.04 (0.84-1.30) 
1.18 (0.95-1.47) 
1.16 (0.91-1.46) 
1.34 (1.03-1.73) 
1.39 (1.06-1.84) 
1.08 (1.02-1.15) 
1.09 (1.02-1.16) 
0.01 
0.01 
Atopic asthma (n=5,228)        
ORa (95% CI) 1.00 1.75 (1.20, 2.57) 1.28 (0.84, 1.94) 2.17 (1.43, 3.28) 1.97 (1.20, 3.25) 1.17 (1.05, 1.30) 0.005 
ORb (95% CI) 1.00 1.79 (1.20, 2.65) 1.33 (0.86, 2.04) 2.07 (1.34, 3.21) 2.07 (1.23, 3.48) 1.16 (1.04, 1.30) 0.01 
Table E4. Comparison of associations of childhood atopy and atopic asthma with maternal free sugar intake during pregnancy vs maternal  
intake after pregnancy  
 OR: Odds ratio 
a Controlling only for previously mentioned potential confounders  
b Mutually adjusting for maternal free sugar intake in pregnancy and maternal free sugar intake after pregnancy, in addition to previously 
mentioned potential confounders 
  
 Free sugar intake  
 1st quintile 2nd quintile 3rd quintile    4th quintile     5th quintile Per quintile P-trend 
Atopy (n=5,406)        
Maternal free sugar intake 
in pregnancy 
       
ORa (95% CI) 
ORb (95% CI) 
Maternal free sugar intake 
after pregnancy 
ORa (95% CI) 
ORb (95% CI) 
1.00 
1.00 
 
 
1.00 
1.00 
0.97 (0.78-1.20) 
0.94 (0.75-1.16) 
 
 
1.08 (0.87-1.35) 
1.07 (0.86-1.34) 
1.07 (0.86-1.33) 
1.02 (0.82-1.28) 
 
 
1.23 (0.99-1.54) 
1.20 (0.95-1.51) 
1.16 (0.92-1.46) 
1.10 (0.86-1.41) 
 
 
1.32 (1.04-1.67) 
1.24 (0.97-1.60) 
1.37 (1.04-1.80) 
1.34 (0.99-1.79) 
 
 
1.19 (0.89-1.58) 
1.04 (0.77-1.42) 
1.08 (1.02-1.15) 
1.07 (1.00-1.14) 
 
 
1.06 (1.00-1.13) 
1.04 (0.97-1.11) 
0.01 
0.06 
 
 
0.07 
0.33 
Atopic asthma (n=4,840) 
Maternal free sugar intake 
in pregnancy 
       
ORa (95% CI) 1.00 1.75 (1.18-2.59) 1.25 (0.82-1.93) 2.14 (1.40-3.28) 1.84 (1.10-3.09) 1.15 (1.03-1.28) 0.01 
ORb (95% CI) 1.00 1.73 (1.17-2.58) 1.24 (0.80-1.93) 2.11 (1.35-3.32) 1.86 (1.06-3.24) 1.14 (1.01-1.29) 0.03 
Maternal free sugar intake 
after pregnancy 
       
ORa (95% CI) 1.00 0.97 (0.66-1.44) 1.25 (0.85-1.86) 1.29 (0.85-1.97 1.18 (0.71-1.96) 1.07 (0.96-1.20) 0.23 
ORb (95% CI) 1.00 0.91 (0.61-1.35) 1.11 (0.74-1.67) 1.07 (0.69-1.67) 0.94 (0.54-1.63) 1.02 (0.90-1.15) 0.80 
Table E5. Associations between maternal free sugar intake in pregnancy and childhood asthma status between 7 and 14 years* 
 
 
 
 
 
 
OR: Odds ratio 
* No asthma at 7 or 14 years was considered as baseline category (n=4,250) 
a Controlling for energy intake, smoking, infections, supplements, antibiotics and paracetamol use during pregnancy; maternal educational level, 
housing tenure, financial difficulties, ethnicity, age, parity, history of atopic diseases, anxiety; sex of child, season of birth, multiple pregnancy, 
breastfeeding duration 
 
 Remittent asthma (n=675) Incident asthma (n=349) Persistent asthma (n=428) 
 ORa (95% CI) P trend ORa (95% CI) P trend ORa (95% CI) Ptrend 
Free sugar  
   1st quintile 
   2nd quintile 
   3rd quintile 
   4th quintile  
   5th quintile 
   Per quintile 
 
1.00 
1.07 (0.83, 1.39) 
0.87 (0.66, 1.15) 
1.07 (0.80, 1.43) 
1.05 (0.75, 1.48) 
1.01 (0.93, 1.09) 
 
 
 
 
 
 
0.86 
 
1.00 
1.09 (0.77, 1.54) 
1.05 (0.73, 1.51) 
0.89 (0.59, 1.33) 
1.40 (0.89, 2.19) 
1.04 (0.93, 1.15) 
 
 
 
 
 
 
0.49 
 
1.00 
1.38 (1.00, 1.91) 
1.20 (0.85, 1.69) 
1.49 (1.04, 2.13) 
1.25 (0.81, 1.93) 
1.06 (0.96, 1.16) 
 
 
 
 
 
 
0.24 
